Adicet Bio (NASDAQ:ACET) Major Shareholder Purchases $535,472.28 in Stock
Ra Capital Management, L.P., a major shareholder in Adicet Bio (NASDAQ:ACET), recently increased its stake by purchasing 74,268 shares for $535,472.28 at an average cost of $7.21 per share. This transaction, occurring on February 19th, increased their total holdings to 1,107,873 shares, representing a 7.19% increase in their position. Other recent purchases by Ra Capital Management in February include 74,751 shares at $7.27 and 74,577 shares at $7.04.
MAR 2·TradingView▼
Adicet Bio Inc expected to post a loss of $2.80 a share - Earnings Preview
Adicet Bio Inc (ACET) is projected to report a loss of $2.80 per share in its upcoming earnings. This earnings preview provides a brief financial outlook for the company based on Refinitiv data.
JAN 15·Nasdaq▲
Adicet Bio (ACET) Price Target Increased by 1,210.53% to 101.59
The average one-year price target for Adicet Bio (ACET) has significantly increased by 1,210.53% to $101.59 per share, up from the prior estimate of $7.75. This revised target is an average of analyst estimates ranging from $18.18 to $151.20, representing an 1,125.48% increase from its last closing price of $8.29. Institutional ownership in ACET remains high at 72 funds, holding 52,987K shares, and a bullish put/call ratio of 0.07.
